Northwestern Mutual Wealth Management CO Actinium Pharmaceuticals, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 107 shares of ATNM stock, worth $165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107
Previous 107
-0.0%
Holding current value
$165
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$2.51 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$1.07 Million0.0% of portfolio
-
State Street Corp Boston, MA621KShares$962,6660.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$773,8530.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $39M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...